摘要
目的:研究去氢木香内酯对大鼠肝损伤模型的保护作用。方法:以氨基半乳糖、四氯化碳建立大鼠肝损伤模型,分别设正常对照组、模型组、阳性药对照组(0.2 mg/kg)、去氢木香内酯高、中、低剂量组(45 mg/kg,15 mg/kg,5 mg/kg),测定各组大鼠血清中丙氨酸氨基转移酶(Alanine Aminotransferase,ALT)、天门冬酸氨基转移酶(Aspartate Aminotransferase,AST)活性及肝组织中丙二醛(Malondialdehyde,MDA)含量。另以HE、Masson染色,对各组大鼠肝脏作病理检查。结果:与模型组相比,去氢木香内酯可显著降低大鼠血清ALT、AST的活性及MDA的含量(P<0.05),减轻大鼠肝脏坏死性病理改变。结论:去氢木香内酯对大鼠肝脏损伤有较好的保护作用。
Objective: To investigate the protective effect of Dehydrocostus lactone on liver injury in experimental rats. Methods:Rats were injected with galactosamine and carbon tetrachloride to induce liver injury. The model rats were randomly divided into normal group,vehicle control,positive control group( 0. 2 mg·kg- 1),high,middle,and low Dehydrocostus lactone dose groups( 45,15 and 5 mg·kg). The changes of activity of ALT,AST in serum and MDA content in liver tissue were measured. The pathologic change of liver tissue was examined under light microscope by HE and Masson staining. Results: Compared with the vehicle group,Dehydrocostus lactone remarkably decreased( P 0. 05) the activities of ALT,AST in serum and MDA content in liver tissue. It was observed that Dehydrocostus lactone could significantly alleviate the necrotic pathologic change of liver tissue.Conclusion: Dehydrocostus lactone has protective effects on liver injury in labortary rats.
出处
《世界中医药》
CAS
2015年第3期399-402,共4页
World Chinese Medicine
基金
重大新药创制国家科技重大专项(编号:2012ZX09103201-055)
国家自然科学基金项目(编号:81274133
81303261)
中国中医科学院自主选题项目(编号:ZZ2014005
ZZ2014060)
关键词
去氢木香内酯
肝损伤
氨基半乳糖
四氯化碳
Dehydrocostus lactone
Liver injury
Galactosamine
Carbon tetrachloride